Tatva Chintan Pharma Chem Limited

NSEI:TATVA Voorraadrapport

Marktkapitalisatie: ₹20.0b

Tatva Chintan Pharma Chem Dividend

Dividend criteriumcontroles 1/6

Tatva Chintan Pharma Chem is een dividendbetalend bedrijf met een huidig rendement van 0.23% dat ruimschoots wordt gedekt door de winst.

Belangrijke informatie

0.2%

Dividendrendement

0%

Terugkoop Rendement

Totaal aandeelhoudersrendement0.2%
Toekomstig dividendrendement0.4%
Dividendgroei49.1%
Volgende betaaldatum dividendn/a
Ex-dividenddatumn/a
Dividend per aandeel₹2.000
Uitbetalingsratio15%

Recente dividendupdates

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Hoewel de dividendbetalingen stabiel zijn, betaalt TATVA nog geen 10 jaar dividend uit.

Groeiend dividend: TATVA betaalt pas 3 jaar dividend uit en sindsdien zijn de betalingen niet verhoogd.


Dividendrendement versus markt

Tatva Chintan Pharma Chem Dividendrendement versus markt
Hoe verhoudt TATVA dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (TATVA)0.2%
Markt onderkant 25% (IN)0.2%
Markt Top 25% (IN)1.1%
Gemiddelde industrie (Chemicals)0.7%
Analist prognose (TATVA) (tot 3 jaar)0.4%

Opmerkelijk dividend: Het dividend van TATVA ( 0.23% ) is niet noemenswaardig vergeleken met de onderste 25% van de dividendbetalers op de Indian markt ( 0.24% ).

Hoog dividend: Het dividend TATVA ( 0.23% ) is laag vergeleken met de top 25% van dividendbetalers in de Indian markt ( 1.1% ).


Winstuitkering aan aandeelhouders

Verdiendekking: Met zijn lage payout ratio ( 15.1% ) worden de dividendbetalingen van TATVA ruimschoots gedekt door de winst.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: TATVA keert dividend uit, maar het bedrijf heeft geen vrije kasstromen.


Ontdek bedrijven met een sterk dividend